PerkinElmer (PKI) Tops Q1 EPS by 12c; Offers 2Q EPS/Revenue Outlook, Withdraws FY20 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. CVS
10. SPY

Go back to PerkinElmer (PKI) Tops Q1 EPS by 12c; Offers 2Q EPS/Revenue Outlook, Withdraws FY20 Guidance

PerkinElmer (PKI) Announces FDA Provides Emergency Use Authorization for Serological Test to Identify COVID-19 Antibodies

May 5, 2020 9:15 AM EDT

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for EUROIMMUNs (a PerkinElmer company)... More

PerkinElmer (PKI) COVID-19 antibody test receives emergency approval from FDA

May 4, 2020 10:06 AM EDT

PerkinElmer (NYSE: PKI) COVID-19 antibody test receives emergency approval from FDA

... More